首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   402462篇
  免费   27368篇
  国内免费   4728篇
耳鼻咽喉   5480篇
儿科学   8415篇
妇产科学   10329篇
基础医学   55676篇
口腔科学   12104篇
临床医学   33133篇
内科学   81174篇
皮肤病学   8739篇
神经病学   28427篇
特种医学   14782篇
外国民族医学   91篇
外科学   63421篇
综合类   15330篇
现状与发展   5篇
一般理论   64篇
预防医学   19012篇
眼科学   10114篇
药学   33892篇
  20篇
中国医学   3769篇
肿瘤学   30581篇
  2021年   3380篇
  2020年   2537篇
  2019年   3482篇
  2018年   5269篇
  2017年   4179篇
  2016年   4226篇
  2015年   5142篇
  2014年   7028篇
  2013年   8732篇
  2012年   12114篇
  2011年   12148篇
  2010年   7638篇
  2009年   7031篇
  2008年   10857篇
  2007年   11746篇
  2006年   11703篇
  2005年   10712篇
  2004年   9919篇
  2003年   9738篇
  2002年   9227篇
  2001年   29101篇
  2000年   29479篇
  1999年   24258篇
  1998年   5351篇
  1997年   4473篇
  1996年   3938篇
  1995年   3739篇
  1994年   3306篇
  1993年   2972篇
  1992年   16168篇
  1991年   14928篇
  1990年   14270篇
  1989年   14036篇
  1988年   12642篇
  1987年   12131篇
  1986年   11138篇
  1985年   10354篇
  1984年   6925篇
  1983年   5609篇
  1982年   2720篇
  1979年   5477篇
  1978年   3345篇
  1977年   2963篇
  1975年   2636篇
  1974年   3064篇
  1973年   2863篇
  1972年   2828篇
  1971年   2773篇
  1970年   2509篇
  1969年   2543篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.

Background

Although it is known that women do not participate in trials as frequently as men, there are limited recent data examining how women recruitment has changed over time.

Methods

We conducted MEDLINE search using a validated strategy for randomized trials published in New England Journal of Medicine, Lancet, and Journal of the American Medical Association between 1986 and 2015, and included trials evaluating pharmacologic or nonpharmacologic therapies. We abstracted data on demographics, intervention type, clinical indication, and trial design characteristics, and examined their relationships with women enrollment.

Results

In total, 598 trials met inclusion criteria. Women enrollment increased significantly over time (21% between 1986 and 1990 to 33% between 2011 and 2015; Pfor trend < 0.001) and did not differ by journal or funding source. Women enrollment varied with clinical indication, comprising 37% for non–coronary artery disease vascular trials, 30% for coronary artery disease trials, 28% for heart failure trials, and 28% for arrhythmia trials (P < 0.001), which were all significantly lower than the expected proportion in disease populations (P < 0.001). Women enrollment varied with trial type (31%, 29%, and 26% for pharmacologic, device, and procedural trials, respectively; P = 0.001). These findings were corroborated using multivariable analysis. We found significant positive correlations between women enrolled, and mean age and total number of participants. Fewer women were enrolled in trials reporting statistically significant results than those who did not (P = 0.001).

Conclusions

Although enrollment of women has increased over time, it remains lower than the relative proportion in the disease population. Future studies should elucidate the reasons for persistent under-representation of women in clinical trials.  相似文献   
62.
63.
64.
65.
66.
67.

BACKGROUND CONTEXT

Lumbar spinal stenosis (LSS) can impair blood flow to the spinal nerves giving rise to neurogenic claudication and limited walking ability. Reducing lumbar lordosis can increases the volume of the spinal canal and reduce neuroischemia. We developed a prototype LSS belt aimed at reducing lumbar lordosis while walking.

PURPOSE

The aim of this study was to assess the short-term effectiveness of a prototype LSS belt compared to a lumbar support in improving walking ability in patients with degenerative LSS.

STUDY DESIGN

This was a two-arm, double-blinded (participant and assessor) randomized controlled trial.

PATIENT SAMPLE

We recruited 104 participants aged 50 years or older with neurogenic claudication, imaging confirmed degenerative LSS, and limited walking ability.

OUTCOME MEASURES

The primary measure was walking distance measured by the self-paced walking test (SPWT) and the primary outcome was the difference in proportions among participants in both groups who achieved at least a 30% improvement in walking distance from baseline using relative risk with 95% confidence intervals.

METHODS

Within 1 week of a baseline SPWT, participants randomized to the prototype LSS belt group (n=52) and those randomized to the lumbar support group (n=52) performed a SPWT that was conducted by a blinded assessor. The Arthritis Society funded this study ($365,000 CAN) with salary support for principal investigator funded by the Canadian Chiropractic Research Foundation ($500,000 CAN for 5 years).

RESULTS

Both groups showed significant improvement in walking distance, but there was no significant difference between groups. The mean group difference in walking distance was ?74 m (95% CI: ?282.8 to 134.8, p=.49). In total, 62% of participants wearing the prototype LSS belt and 82% of participants wearing the lumbar support achieved at least 30% improvement in walking distance (relative risk, 0.7; 95% CI: 0.5–1.3, p=.43).

CONCLUSIONS

A prototype LSS belt demonstrated significant improvement in walking ability in degenerative LSS but was no better than a lumbar support.  相似文献   
68.
69.
Objectives:To review the experience of 2 tertiary centers in Saudi Arabia with intracranial hypertension (IH) in the pediatric population.Methods:We retrospectively reviewed and analyzed pediatric patients diagnosed with IH from June 2002 to May 2017 in 2 institutes.Results:We identified 53 patients (30 females and 23 males) with a mean age of 7 years at the time of presentation. Among them, 41 patients were younger than 12 years, and 12 were older. Obese and overweight patients constituted 27.00% (n = 14) of all cases, 8 (66.7%) of whom were older than 12 years. The most common presenting feature was papilledema followed by headache. Vitamin D deficiency, which constituted the most common associated condition, was identified in 12 (22.6%) patients. Acetazolamide was the treatment option in 98.11% of patients, and only 5.7% underwent surgical interventions. The length of follow-up ranged from 6 months to 8 years.Conclusion:Intracranial hypertension is rare in children and commonly seen in overweight females older than 12 years similar to adults. Patients younger than 12 years tend to develop secondary IH. More studies are needed to characterize the clinical presentation and guide the management plan.

Intracranial hypertension (IH) is rarely reported in children. It is characterized by increased intracranial pressure (ICP) without any evidence of underlying brain pathology, structural abnormalities, hydrocephalus, or any abnormal meningeal enhancement.1 The incidence of IH differs from region to region due to variations in the prevalence of obesity and other secondary causes. The annual incidence of IH in children is 0.9 per 100,000 in the United States,2 0.5 per 100,000 in Germany,3 0.6 per 100,000 in Nova Scotia and Prince Edward Island in Eastern Canada,4 and 1.2 per 100,000 in Croatia.5 A study carried out in Oman estimated the incidence of IH to be 1.9 per 100,000 in children below 15 years of age; with it being higher in female children.6 The present study aimed to review the clinical presentation, possible aetiological factors, diagnosis, management, and outcomes in children with IH in 2 tertiary institutes in Saudi Arabia.  相似文献   
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号